Oxidative injury and antioxidant vitamins E and C in Schizophrenia

Susceptibility of Schizophrenic patients to lipid peroxidation relative to healthy control subjects was investigated by measuring the malondialdehyde (MDA) levels in plasma. The main finding was that Schizophrenic patients were more susceptible than control subjects to oxidative damage as evident from increased MDA levels in plasma. Antioxidant levels are also depleted in Schizophrenic patients when compared to normal subjects as evident from decreased levels of vitamins E and C in the plasma. Impaired antioxidant defense and increased lipid peroxidation suggests that treatment with antioxidants (Vitamin E, Vitamin C, beta carotene) at the initial stages of illness may prevent further oxidative injury and deterioration of associated neurological deficits in Schizophrenia.

[1]  B. Belavady.,et al.  Serum Vitamin E Levels in a Normal Adult Population in the Washington, D. C., Area , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  J. Stocks,et al.  The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide , 1971, British journal of haematology.

[3]  D. Graham.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. , 1978, Molecular pharmacology.

[4]  Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978 .

[5]  P. Ward,et al.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. , 1982, The American journal of pathology.

[6]  H. A. Winkler.  The Practitioner's Guide to Psychoactive Drugs , 1983 .

[7]  Roslyĭ Im,et al.  Lipid peroxidation in the blood of patients with suppurative meningitis , 1990 .

[8]  J. Cooper,et al.  Mitochondrial function in neurodegeneration and ageing. , 1992, Mutation research.

[9]  P. Mecocci,et al.  Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.

[10]  L. Adler,et al.  Vitamin E in tardive dyskinesia: time course of effect after placebo substitution. , 1993, Psychopharmacology bulletin.

[11]  S. Akhtar,et al.  Vitamin E in the treatment of tardive dyskinesia. , 1993, Journal of postgraduate medicine.

[12]  J. Baraban,et al.  APOPTOTIC AN IN AN IN VITRO MODEL OF NEURONAL OXIDATIVE STRESS , 1995, Clinical and experimental pharmacology & physiology.

[13]  S. Mahadik,et al.  Oxidative injury and potential use of antioxidants in schizophrenia. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[15]  S. Mukherjee,et al.  Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis , 1998, Biological Psychiatry.

[16]  D. Kouretas,et al.  Lipid peroxidation and tissue damage. , 1999, In vivo.

[17]  A. Rao,et al.  Oxidative stress and antioxidants in epilepsy. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[18]  V. Gupta,et al.  Oxygen derived free radicals in clinical context , 2008, Indian Journal of Clinical Biochemistry.